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Abstract. Epithelial to mesenchymal transition (EMT) is 
a feature of several types of human cancer, including oral 
squamous cell carcinoma (OSCC). In the present study, tumor 
and margin cell cultures obtained from patients with OSCC 
were used to determine the expression patterns of certain 
EMT-associated markers, including vimentin, α-smooth muscle 
actin, SLUG and SNAIL. In addition, other EMT-associated 
features, including clonal, proliferative and migratory poten-
tial were compared between the two cell types. Cell cultures 
were generated from tumor and margin tissue samples from 
6 patients and cultured up to the fifth passage. EMT marker 
expression was assessed by reverse transcription-quantitative 
PCR. Cell proliferation, colony formation and scratch wound 
healing assays were conducted to characterize the two cell 
types in terms of proliferation rates, clonality and motility. All 
of the studied markers were expressed in tumor and margin 
cells. Although no significant differences were noted with 
regard to the aforementioned markers, their expression tended 
to be higher in margin cultures than in tumor cultures. The 
expressions of the EMT markers were also higher in the fifth 
passage compared with those noted at the first with a few 
exceptions. The rates of proliferation and cell migration were 
decreased during passages, while the number of colonies was 
increased in both types of cell culture. Tumor and margin cells 
indicated certain similarities with regard to EMT transition 
characteristics.
Introduction
The epithelial to mesenchymal transition (EMT) induces loss 
of cell epithelial phenotype and has been initially described 
in the process of embryonic development (1). The EMT 
process is also a hallmark of several human cancers and as 
EMT progresses tumor cells become motile and increase their 
aggressiveness (2‑4). Oral cancer and more specifically oral 
squamous cell carcinoma (OSCC) is a very common malig-
nancy. It is characterized by high propensity to recurrence 
and metastasis and a relatively modest 5-year survival rate. 
Approximately 40 to 50% of OSCC recurrence is believed 
to occur in part due to EMT. Differentiated epithelial cancer 
cells achieve a dedifferentiated mesenchymal appearance by 
EMT along with the capacity to dissociate from each other 
and migrate (5).
SLUG and SNAIL are the main transcriptional repressors 
of E-cadherin and are considered the principal mediators of 
EMT (5-7). Upregulation of the mesenchymal intermediate 
filament proteins α-SMA and Vimentin is also a typical event 
in the course of EMT, leading to disturbed epithelial integ-
rity (8,9). 
EMT occurs only in certain types of cancer cells that 
are localized predominantly at the tumor front, while other 
cancer cells retain their epithelial traits. Therefore, the tran-
sient nature of EMT and the heterogeneity of the degree of 
dedifferentiation pose a challenge for the establishment of 
appropriate in vivo studies (10). Recently, a strong association 
between EMT and cancer stem cells (CSCs) has also been 
revealed. It was shown that CSCs represent a plastic state of 
tumor cells undergoing EMT, induced either by cell-intrinsic 
and/or microenvironment-associated signals (11). In addition, 
previous studies have shown the presence of CSCs in the tumor 
margins (12). Therefore, the current study examined whether 
EMT was present in that specific area. EMT has been studied 
in the margin tissue of a limited number of cancers [breast (13), 
colon (14), lung (15)] but not in the resection margins of oral 
cancer, although it is well known that the histological and 
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molecular status of the margins are determinants of tumor 
behavior (16,17).
The present study aimed to investigate OSCCs and their 
resection margins in terms of mRNA expression of the EMT 
markers Vimentin, α‑SMA, SLUG and SNAIL in tumor and 
margin primary cell cultures during specific cell passages. 
Moreover, the present study investigated EMT-associated 
features, including the clonal, proliferative and migratory 
potential of tumor and margin cells.
Materials and methods
Patients and tissues. In order to investigate the incidence 
of EMT in OSCC, tumor and margin tissues of 6 patients 
(2 females and 4 males, average age 59.5±9.33, 3 tongue and 
3 floor of the mouth tumors) diagnosed with OSCC were 
obtained at the Clinic of Maxillofacial Surgery of the School 
of Dental Medicine at the University of Belgrade. The samples 
were processed by immunostaining. Deparaffinization of 
5-µm tissue sections was performed in xylene. The process 
was repeated two times for 5 min. The sections were processed 
by hydration with graded ethanol (100, 96, 80, 70, 50%) 2x for 
5 min. Pretreatment was performed in 0.1 ml citrate buffer 
(pH 6.0) for 20 min at 98̊C. The samples were incubated in 
3% H2O2 for 5 min and rinsed in Tris-buffered saline solu-
tion. This was followed by application of the UV blocker for 
5 min. The samples were incubated with rabbit polyclonal 
antibodies for Vimentin, α-SMA, SNAIL and SLUG (Thermo 
Fisher Scientific) for 20 min. Following rinsing for 5 min, 
the samples were analyzed with Quatro amplifier for 10 min, 
Quatro polymer for 10 min, DAB quatro for 5 min and finally 
counterstained with hematoxylin for 2 min. Between all these 
phases, the samples were rinsed for 5 min. The images were 
captured by the Olympus DP70 camera and the Olympus 
BX50 microscope (Olympus).
Cell and tissue culture. OSCC tumor and margin tissues were 
obtained immediately prior to the surgery. Tumor margins 
were obtained 5 mm from the edges of the tumor. The SCC-25 
cancer cell line (ATCC® CRL-16 28™) was used as the nega-
tive control sample. Fibroblasts isolated from gingiva of heathy 
donors were used as the positive control sample. The present 
study was approved by the Institutional Ethics Committee 
(no. 36/31) and conducted in accordance with the Declaration 
of Helsinki. The patients were informed of the study protocol 
and signed a written informed consent form. The histopatho-
logical diagnosis of OSCC was established in accordance with 
the World Health Organization (WHO) guidelines and the 
tumor staging was performed using the TNM classification. 
Margin samples were obtained at least 5 mm from the edges 
of the surgical defects following primary tumor excision and 
the absence of neoplastic cells was histologically confirmed. 
Dulbecco's modified Eagle's medium (DMEM) supplemented 
with 20% fetal bovine serum (FBS) and 100 U/ml peni-
cillin-100 µg/ml streptomycin (Sigma-Aldrich; Merck KGaA) 
was used for tissue culture. The tissue samples were homog-
enized with blades into 1 mm3 pieces and washed 3 times with 
PBS to remove loosely bound cells, as previously described. 
An explant-cell culture system (12,18) was carried out with 
periodical removal of fibroblasts using differential trypsiniza-
tion (19). The cells were grown in DMEM supplemented with 
10% FBS and 100 U/ml penicillin-100 µg/ml streptomycin in 
T75 cell culture flasks. A 1:1 mixture of DMEM and Ham's 
F12 medium supplemented with 400 ng/ml hydrocortisone and 
10% FBS was used for the SCC-25 cell culture. SCC-25 cells 
used for the study were at the 10th passage. The cells were 
preserved at 37̊C in a humidified atmosphere containing 
5% CO2. The medium was changed every 2-3 days and the 
cells were passaged prior to reaching 80% confluence. A total 
of 5x105 cells were plated for the next passage. The tissue cells 
were designated as tumor tissue (Tu) and margin tissue (M) 
cells. These cells were obtained following the first (P1) and the 
fifth (P5) passage (Fig. 1). All experiments were performed in 
triplicate and repeated for three times.
RNA extraction and reverse transcription‑quatintitative 
(RT‑q) PCR. Total RNA was extracted from OSCC and margin 
cells, SCC‑25 and fibroblasts (106 cells per tube) using TRIzol 
(Invitrogen; Thermo Fisher Scientific, Inc.). Complementary 
DNA was prepared using the Revert Aid First Strand cDNA 
synthesis kit (Thermo Fisher Scientific, Inc.) according to the 
manufacturer's instructions. Subsequently, RT-qPCR analysis 
was performed on a Line Gene-K Fluorescence Real-time PCR 
Detection System (Bioer Technology, Inc.) using Maxima™ 
SYBR-Green/ROX qPCR Master Mix (Thermo Fisher 
Scientific Inc.). The expression of GAPDH (housekeeping 
gene) was used for normalization. The 2-ΔΔct method was used 
for the relative quantification of gene expression as described 
by Livak and Schmittgen (20). All oligonucleotide primers 
were purchased from Sigma-Aldrich; Merck KGaA and their 
sequences are provided in Table I.
Protein extraction and western blotting. The cells were 
resuspended in RIPA lysis buffer (50 mM Tris-HCl pH 7.6, 
150 mM sodium chloride, 1% Triton X-100, 1% sodium 
deoxycholate, 0.1% sodium dodecyl sulphate, 2 mM EDTA 
and 50 mM sodium fluoride). A protease inhibitor cocktail 
(Pierce Biotechnology, Inc.) and sodium orthovanadate 
(Sigma-Aldrich; Merck KGaA) were added to the lysis 
buffer prior to use. Western blotting was conducted by 
running equal amount protein samples on polyacrylamide 
gels. The proteins were transferred from the gels to poly-
vinylidene difluoride (PVDF) membrane. The experiment 
was performed in duplicate. The membranes were first 
probed with primary antibodies against anti-vimentin 
(Santa Cruz Biotechnology, Inc.; cat. no. sc-32322, 1:200), 
then stripped with Restore Western Blot Stripping Buffer 
(cat. no. 21059, Thermo Fisher Scientific, Inc.) according 
to manufacture's instructions. After that, the membranes 
were probed with anti-alpha smooth muscle actin antibody 
(Abcam; cat. no. ab7817, 1:300). After stripping again with 
same buffer, membranes were probed with β-actin (R&D; 
cat. no. MAB8929, 1:6,000). Peroxidase-conjugated goat 
antimouse immunoglobulin (Thermo Fisher Scientific, Inc.; 
cat. no. 31430, 1:5,000) was used as the secondary antibody. 
Hyperfilm was used to visualize the protein expression by 
a chemiluminescent reagent kit (Abcam; cat. no. ab79907) 
according to the manufacturer's instructions. The content of 
Vimentin and α-SMA in the tumor and margin cell cultures 
was estimated by densitometry of the scanned immunoblot 
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bands using the Image Lab (Bio-Rad) software and normal-
ized to the β-actin protein density.
Colony formation assay. The cells were seeded in the 12-well 
plate at a concentration of 104 cells per well in DMEM 
supplemented with 10% FBS. Tumor and margin cells were 
incubated (37̊C, 5% CO2) and the number of live cells was 
counted following 3, 5, and 7 days of incubation period.
A total of 200 cells were plated per well in 32 mm-wide 
plates and cultured in 1.5 ml of DMEM supplemented with 
10% FBS for 7 and 14 days. The cell colonies were washed 
with PBS, fixed in formalin for 5 min and stained with 0.05% 
crystal violet for 30 min at room temperature. Following 
removal of the dye, the colonies with more than 50 cells were 
counted as positive using the ImageJ software. The results are 
presented as colony formation efficiency (21) and as the ratio 
between the number of colonies formed and the number of 
seeded cells.
Wound healing assay. A wound healing assay was conducted 
to detect cell motility (22). Single-cell suspensions of margins 
and tumors were added to 24-well plates (2x105 cells/well in 
0.7 ml of DMEM supplemented with 10% FBS) and cultured 
for 4‑5 days to a confluence of approximately 80%. The mono-
layer was scratched with a sterile 1.2 mm-wide pippete tip 
across the center of the well in a straight line to cause a wound 
in the confluent cell monolayer. Subsequently, the wells were 
washed with PBS and grown in the incubator with serum-free 
DMEM (37̊C, 5% CO2). A BIB-100/T inverted microscope 
and HDCE-90D camera with Scope Image 9.0 software 
(BOECO Germany) were used to measure the closest area of 
the scratch. Cell migration was calculated by monitoring the 
entire movement of the monolayer. The shortest distance was 
measured between the separated monolayers and divided with 
time. The cell speed, measured in µm/h, was calculated for 
all 24 h intervals until the scratch area was closed, as follows:
S (Iday)=d(0 h)‑d(24 h) S (IIday)=d(24 h)‑d(48 h) 
 24 24
S(IIIday)= d(48 h)‑d(72 h)
 24
The average cell speed was S= S (Iday) + S (IIday) + S(IIIday)
 3
Statistical analysis. One-way or two-way ANOVA tests, 
with Tukey's post hoc comparison were performed in the 
present study, after checking the distribution normality by 
Kolmogorov-Smirnov normality test. The values are presented 
as mean ± SD. Statistical significance was set at P<0.05. The 
software package GraphPad Prism version 6 was used for the 
analyses (GraphPad Software, Inc.).
Results
Vimentin, α‑SMA, SLUG and SNAIL are expressed in tumor 
and margin samples. Prior to undertaking mRNA expression 
analyses in cell cultures, the presence of EMT markers was 
determined by immunohistochemical analysis of fixed tissue 
specimens. Tumors and resection margins were used from 
Figure 1. Representative micrographs of (A) tumor and (B) margin cells of the fifth passage (magnification, x40).
Table I. Primers used for expression analysis.
Primer name Sequence (5'→3')
Vimentin
  Forward TCTACGAGGAGGAGATGCGG
  Reverse GGTCAAGACGTGCCAGAGAC
α-SMA
  Forward CAATGGCTCTGGGCTCTGTAAG
  Reverse TGTTCTATCGGGTACTTCAGGGTC
SNAIL
  Forward ACCACTATGCCGCGCTCTT
  Reverse GGTCGTAGGGCTGCTGGAA
SLUG
  Forward TGTTGCAGTGAGGGCAAGAA
  Reverse GACCCTGGTTGCTTCAAGGA
GAPDH
  Forward TCATGACCACAGTCCATGCCATCA
  Reverse CCCTGTTGCTGTAGCCAAATTCGT
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patients for establishing cell cultures. A clear immunostaining 
could be observed for all the markers (Vimentin, α-SMA, 
SLUG and SNAIL) in the tumors as well as in their margins. 
The representative micrographs are shown in Fig. 2.
RT-qPCR analysis was used to detect the expression levels 
of the epithelial to mesencymal transition markers (Vimentin, 
α-SMA, SLUG and SNAIL) in both tumor and margin cells. 
The expression levels in these two types of cells were different. 
However, no significanct difference was noted (P>0.05). 
Vimentin was the marker that exhibited the highest levels of 
expression in both OSCC and margin cells and as expected in 
fibroblast cultures. However, these results were not noted in 
the oral cancer cell line SCC-25, which maintained its epithe-
lial characteristics during cultivation. The levels of Vimentin 
mRNA were higher in tumor and margin cells at the begin-
ning of cultivation (1st passage) than in the cells of the 5th 
passage. However, the differences noted were not significant. 
In contrast, the relative gene expression levels of α-SMA (in 
margin cultures) and SNAIL (in tumor cultures) were higher 
in the 5th passage compared with those of the 1st passage 
(P<0.05) (Fig. 3). This trend was also noted in the expression 
levels of SLUG in tumor cells.
In order to confirm the findings obtained by qPCR anal-
ysis, the protein expression levels of the two EMT markers 
Vimentin and α-SMA were examined. Protein expression 
was in line with mRNA levels, although without statistically 
significant differences between passages (Fig. 4).
The proliferation rate of tumor and margin cells depends 
on their passage number. The number of cells was increased 
during the 7-day assay duration, with the exception of the 5th 
passage margin cells. The differences noted between tumor 
and margin cells were evident in the 5th passage of cells. 
Tumor cells exhibited higher proliferative potential (Fig. 5A). 
Generally, in both tumor and margin cells, the proliferation 
rates decreased from the 1st to the 5th passage.
The differences noted with regard to the colony formation 
ability were statistically significant from the 7th to the 14th 
day (P<0.05). The number of colonies formed by the tumor 
cells (1.25 and 15.25 following 7 and 14 days of incubation, 
respectively), and margin cells (2.33 and 17.67 following 7 and 
14 days of incubation, respectively) was similar. The colony 
formation efficiency is provided in Fig. 5B. No significant 
differences were noted in that parameter during different 
passages. The motility of the tumor and margin cells did not 
exhibit significant differences between cell passages (Fig. 6). 
The average value of cell speed during the 72 h period is given 
in Fig. 6Q.
Discussion
The poor prognosis of OSCC is mainly caused due to 
the high recurrence and metastasis rates and remains a 
significant medical challenge, regardless of the advances 
in diagnostic and therapeutic procedures (23,24). Recent 
studies have recognized EMT as a critical process during 
tumor cell invasion of the surrounding stroma, which may 
explain specific essential steps leading to metastasis and 
tumor recurrence.
The present study hypothesized that EMT occurs pref-
erentially at the tumor margin, which is the site of vessel 
-invasion (13,14,25). Consequently, margin tissue samples 
were used in addition to resected OSCC samples in order 
to establish cell cultures and assess their corresponding 
EMT-associated features. All EMT markers (Vimentin, 
α-SMA, SNAIL, SLUG) were expressed in both types of cells 
Figure 2. Immunostaining of epithelial to mesenchymal transition markers. (A) vimentin, (B) α-smooth muscle actin, (C) SLUG and (D) SNAIL were assessed 
(magnification,x50).T, tumor; M, margin.
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(tumor and margin) at various levels. The expression levels of 
these markers did not exhibit significant differences between 
cancer and margin cells, although, they were significantly 
higher in the margin tissues.
In the present study, high levels of Vimentin mRNA were 
detected in both tumor and margin cell cultures. The migratory 
Figure 3. Expression of epithelial to mesenchymal transition-associated markers in tumor, margin and control cell cultures. (A) Vimentin, (B) α-SMA, (C) Slug 
and (D) Snail expression. The SCC-25 cancer cell line was used as a negative control sample, whereas Fb isolated from gingiva were used as positive control 
samples. Data are presented as the mean ± standard deviation. *P<0.05 as indicated. EMT, epithelial to mesenchymal transition; Fb, fibroblasts; SMA, smooth 
muscle actin; TuP1, tumor cells derived from the first passage; TuP5, tumor cells of the fifth passage; MP1, margin cells of the first passage; MP5, margin cells 
of the fifth passage.
Figure 4. Western blot analysis. (A) vimentin and (B) α-SMA expression. 
(C) Represenetative western blot analysis. The SCC-25 cancer cell line was 
used as a control. Data presented as the mean ± standard deviation. TuP, tumor 
tissue passage; MP, margin tissue passage. SMA, smooth muscle actin; TuP1, 
tumor cells derived from the first passage; TuP5, tumor cells of the fifth passage; 
MP1, margin cells of the first passage; MP5, margin cells of the fifth passage.
Figure 5. Colony  formation and cell proliferation assays. (A) The number of 
viable cells during 7 day cultivation. (B) The number of cell colonies formed 
on the 7th and 14th day of culture, as determined by a colony formation assay; 
*P<0.05 and **P<0.005 as indicated. TuP1, tumor cells derived from the first 
passage; TuP5, tumor cells of the fifth passage; MP1, margin cells of the first 
passage; MP5, margin cells of the fifth passage.
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potential of the two cell types was highly concordant, prob-
ably due to similar expression levels of Vimentin. Increased 
expression levels of Vimentin are associated with cancer 
progression. This protein is an indicator of high cell migratory 
activity (8,26) which is in agreement with the results of the 
present study.
One of the major factors affecting EMT marker expression 
was cell passaging. The expression levels of the markers were 
increased during cell passages and significant differences were 
established for α-SMA and SNAIL in both types of cells. This 
finding can tentatively be explained by cell culture enrich-
ment with cancer stem cells during passages as determined 
by the increase in the expression levels of CSC markers, such 
as CD44, CD133, Oct4, Sox2 and Nanog (12). This in turn 
reflects to a certain extent the clonal evolution of tumors and 
the increase of aggressiveness during tumor progression. It 
was previously shown that SNAIL exerted an important role in 
inducing and maintaining CSC-like properties by EMT induc-
Figure 6. Representative micrographs of cell migration. Tumor cells of the first passage at (A) 0 h, (B) 24 h, (C) 48 h and (D) 72 h after the scratch. Tumor cells 
of the fifth passage at (E) 0 h, (F) 24 h, (G) 48 h and (H) 72 h after the scratch. Margin cells of the first passage at (I) 0 h, (J) 24 h, (K) 48 h and (L) 72 h after 
the scratch. Margin cells of the fifth passage at (M) 0 h, (N) 24 h, (O) 48 h and (P) 72 h after the scratch. (Q) Average migration was subsequently calculated. 
Magnification, x40. TuP1, tumor cells derived from the first passage; TuP5, tumor cells of the fifth passage; MP1, margin cells of the first passage; MP5, margin 
cells of the fifth passage; d, day.
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tion in OSCC (27). Alternatively, the cells in the culture may 
undergo transdifferentiation during passaging, progressively 
acquiring the mesenchymal phenotype. This phenomenon has 
been previously described in ovarian cancer cells, which can 
synthesize collagen I and II, while gradually losing the expres-
sion of cytokeratin during passaging (28).
The proliferation rates of tumor and margin cells was 
decreased over the passaging period and this finding was 
in accordance with Vega et al (29) and Mejlvang et al (30) 
who demonstrated that the activation of EMT reduces 
cell proliferation. In the present study, tumor and tumor 
margin cells exhibited similar abilities to form colonies, 
which was also accompanied by relevant EMT-associated 
features (31). This similar capacity to form colonies was 
in accordance with the relative homogenous expression of 
the EMT markers analyzed in tumor and margin samples. 
These findings provide additional evidence in favor of the 
concept that EMT is present at multiple sites within the 
tumor, as previously hypotesized (6,32). A recent study 
further demonstrated a characteristic pattern of expression 
for the proteins TWIST1, SNAI1, SNAI2 and ZEB1 in the 
center of primary breast tumors and their margins (33). 
Cancer ‘self-seeding’ ability may be another explanation 
for the remarkable phenotypic similarities of cancer and 
margin cells (34).
The data presented in the present study suggest that the 
EMT markers Vimentin, α-SMA, SNAIL and SLUG were 
similarly expressed in tumor and margin cells of OSCC and 
that cell passaging increased their expression levels. With the 
exception of certain minor differences, the parameters prolif-
eration rate, clonal ability, and migratory capacity were similar 
in the cells originating from tumors and resection margins, 
which suggested the importance of margin pathological status 
in terms of tumor aggressiveness.
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